1. From the Department of Internal Medicine (T.B.T., G.M.D.-T.), University Medical Center, Utrecht, the Netherlands; Hyperlipidemia and Atherosclerosis Research Laboratory (J.S.C.), Clinical Research Institute of Montreal, Montreal, Quebec, Canada; and Dyslipoproteinemia and Atherosclerosis (T.B.T., M.J.C.), Unit 551 National Institute of Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetrière, Paris, France.